# indie Semiconductor, Inc.: financial statements, quarterly INDI · Nasdaq · CIK 1841925 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/indi.md) · [Financials](/companies/indi/financials.md) · [Filings](/companies/indi/filings.md) · [Insiders](/companies/indi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/indi/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [60.5](/filings/0001628280-24-046662.md) | [70.1 d](/filings/0001193125-26-082535.md) | [52.4](/filings/0001628280-25-024788.md) | [52.4](/filings/0000950170-25-105948.md) | [54.0](/filings/0001193125-25-272468.md) | [58.0 d](/filings/0001193125-26-082535.md) | [54.1](/filings/0001193125-26-215104.md) | [51.6](/filings/0001193125-26-340396.md) | [53.7](/filings/0001193125-25-272468.md) | [58.0 d](/filings/0001193125-26-082535.md) | [55.5](/filings/0001193125-26-215104.md) | [64.0](/filings/0001193125-26-340396.md) | | Cost of revenue | $m | [35.2](/filings/0001628280-24-046662.md) | [42.2 d](/filings/0001193125-26-082535.md) | [30.1](/filings/0001628280-25-024788.md) | [30.2](/filings/0000950170-25-105948.md) | [32.7](/filings/0001193125-25-272468.md) | [33.3 d](/filings/0001193125-26-082535.md) | [31.5](/filings/0001193125-26-215104.md) | [30.7](/filings/0001193125-26-340396.md) | [32.2](/filings/0001193125-25-272468.md) | [36.4 d](/filings/0001193125-26-082535.md) | [34.4](/filings/0001193125-26-215104.md) | [40.9](/filings/0001193125-26-340396.md) | | Research and development | $m | [41.6](/filings/0001628280-24-046662.md) | [34.3 d](/filings/0001193125-26-082535.md) | [49.6](/filings/0001628280-25-024788.md) | [41.3](/filings/0000950170-25-105948.md) | [46.0](/filings/0001193125-25-272468.md) | [38.3 d](/filings/0001193125-26-082535.md) | [42.1](/filings/0001193125-26-215104.md) | [38.5](/filings/0001193125-26-340396.md) | [38.0](/filings/0001193125-25-272468.md) | [35.5 d](/filings/0001193125-26-082535.md) | [38.5](/filings/0001193125-26-215104.md) | [37.8](/filings/0001193125-26-340396.md) | | Selling, general and administrative | $m | [19.8](/filings/0001628280-24-046662.md) | [15.2 d](/filings/0001193125-26-082535.md) | [22.3](/filings/0001628280-25-024788.md) | [17.4](/filings/0000950170-25-105948.md) | [20.8](/filings/0001193125-25-272468.md) | [20.3 d](/filings/0001193125-26-082535.md) | [19.4](/filings/0001193125-26-215104.md) | [18.4](/filings/0001193125-26-340396.md) | [20.8](/filings/0001193125-25-272468.md) | [19.2 d](/filings/0001193125-26-082535.md) | [21.4](/filings/0001193125-26-215104.md) | [20.4](/filings/0001193125-26-340396.md) | | Operating income | $m | [(36.1)](/filings/0001628280-24-046662.md) | [(21.6) d](/filings/0001193125-26-082535.md) | [(49.6)](/filings/0001628280-25-024788.md) | [(36.6)](/filings/0000950170-25-105948.md) | [(49.9)](/filings/0001193125-25-272468.md) | [(33.9) d](/filings/0001193125-26-082535.md) | [(38.9)](/filings/0001193125-26-215104.md) | [(43.0)](/filings/0001193125-26-340396.md) | [(38.3)](/filings/0001193125-25-272468.md) | [(33.9) d](/filings/0001193125-26-082535.md) | [(38.9)](/filings/0001193125-26-215104.md) | [(35.1)](/filings/0001193125-26-340396.md) | | Interest expense | $m | [2.2](/filings/0001628280-23-038372.md) | [2.1 d](/filings/0001628280-24-008027.md) | [2.1](/filings/0001628280-24-022356.md) | [2.1](/filings/0000950170-25-105948.md) | [2.2](/filings/0001193125-25-272468.md) | [2.8 d](/filings/0001193125-26-082535.md) | [4.5](/filings/0001193125-26-215104.md) | [4.5](/filings/0001193125-26-340396.md) | [4.3](/filings/0001193125-25-272468.md) | [4.3 d](/filings/0001193125-26-082535.md) | [4.3](/filings/0001193125-26-215104.md) | [4.7](/filings/0001193125-26-340396.md) | | Income tax | $m | [0.7](/filings/0001628280-24-046662.md) | [(1.8) d](/filings/0001193125-26-082535.md) | [(1.1)](/filings/0001628280-25-024788.md) | [0.1](/filings/0000950170-25-105948.md) | [(0.3)](/filings/0001193125-25-272468.md) | [(0.6) d](/filings/0001193125-26-082535.md) | [0.1](/filings/0001193125-26-215104.md) | [0.6](/filings/0001193125-26-340396.md) | [(0.4)](/filings/0001193125-25-272468.md) | [(3.3) d](/filings/0001193125-26-082535.md) | [(0.3)](/filings/0001193125-26-215104.md) | [(0.4)](/filings/0001193125-26-340396.md) | | Net income | $m | [(17.1)](/filings/0001628280-24-046662.md) | [(14.7) d](/filings/0001193125-26-082535.md) | [(31.2)](/filings/0001628280-25-024788.md) | [(19.2)](/filings/0000950170-25-105948.md) | [(49.7)](/filings/0001193125-25-272468.md) | [(32.6) d](/filings/0001193125-26-082535.md) | [(34.5)](/filings/0001193125-26-215104.md) | [(39.0)](/filings/0001193125-26-340396.md) | [(38.3)](/filings/0001193125-25-272468.md) | [(31.2) d](/filings/0001193125-26-082535.md) | [(43.2)](/filings/0001193125-26-215104.md) | [(37.1)](/filings/0001193125-26-340396.md) | | Diluted EPS | $ per share | [(0.12)](/filings/0001628280-24-046662.md) | not reported | [(0.19)](/filings/0001628280-25-024788.md) | [(0.11)](/filings/0000950170-25-105948.md) | [(0.28)](/filings/0001193125-25-272468.md) | not reported | [(0.18)](/filings/0001193125-26-215104.md) | [(0.20)](/filings/0001193125-26-340396.md) | [(0.19)](/filings/0001193125-25-272468.md) | not reported | [(0.21)](/filings/0001193125-26-215104.md) | [(0.17)](/filings/0001193125-26-340396.md) | | Basic EPS | $ per share | [(0.12)](/filings/0001628280-24-046662.md) | not reported | [(0.19)](/filings/0001628280-25-024788.md) | [(0.11)](/filings/0000950170-25-105948.md) | [(0.28)](/filings/0001193125-25-272468.md) | not reported | [(0.18)](/filings/0001193125-26-215104.md) | [(0.20)](/filings/0001193125-26-340396.md) | [(0.19)](/filings/0001193125-25-272468.md) | not reported | [(0.21)](/filings/0001193125-26-215104.md) | [(0.17)](/filings/0001193125-26-340396.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [161](/filings/0001628280-24-046662.md) | [152](/filings/0001628280-25-009207.md) | [138](/filings/0001628280-25-024788.md) | [112](/filings/0000950170-25-105948.md) | [96.9](/filings/0001193125-25-272468.md) | [274](/filings/0001193125-26-082535.md) | [237](/filings/0001193125-26-215104.md) | [193](/filings/0001193125-26-340396.md) | [161](/filings/0001193125-25-272468.md) | [145](/filings/0001193125-26-340396.md) | [174](/filings/0001193125-26-215104.md) | [139](/filings/0001193125-26-340396.md) | | Current assets | $m | [270](/filings/0001628280-23-038372.md) | [272](/filings/0001628280-25-009207.md) | [264](/filings/0001628280-24-022356.md) | [248](/filings/0001628280-24-036484.md) | [241](/filings/0001628280-24-046662.md) | [409](/filings/0001193125-26-082535.md) | [382](/filings/0001628280-25-024788.md) | [332](/filings/0000950170-25-105948.md) | [297](/filings/0001193125-25-272468.md) | [286](/filings/0001193125-26-340396.md) | [327](/filings/0001193125-26-215104.md) | [312](/filings/0001193125-26-340396.md) | | Total assets | $m | [820](/filings/0001628280-23-038372.md) | [819](/filings/0001628280-25-009207.md) | [804](/filings/0001628280-24-022356.md) | [797](/filings/0001628280-24-036484.md) | [797](/filings/0001628280-24-046662.md) | [941](/filings/0001193125-26-082535.md) | [909](/filings/0001628280-25-024788.md) | [868](/filings/0000950170-25-105948.md) | [855](/filings/0001193125-25-272468.md) | [841](/filings/0001193125-26-340396.md) | [870](/filings/0001193125-26-215104.md) | [842](/filings/0001193125-26-340396.md) | | Current liabilities | $m | [149](/filings/0001628280-23-038372.md) | [139](/filings/0001628280-25-009207.md) | [152](/filings/0001628280-24-022356.md) | [93.1](/filings/0001628280-24-036484.md) | [101](/filings/0001628280-24-046662.md) | [84.9](/filings/0001193125-26-082535.md) | [72.0](/filings/0001628280-25-024788.md) | [76.5](/filings/0000950170-25-105948.md) | [79.2](/filings/0001193125-25-272468.md) | [76.5](/filings/0001193125-26-340396.md) | [79.6](/filings/0001193125-26-215104.md) | [85.3](/filings/0001193125-26-340396.md) | | Total liabilities | $m | [407](/filings/0001628280-23-038372.md) | [342](/filings/0001628280-25-009207.md) | [342](/filings/0001628280-24-022356.md) | [295](/filings/0001628280-24-036484.md) | [309](/filings/0001628280-24-046662.md) | [496](/filings/0001193125-26-082535.md) | [477](/filings/0001628280-25-024788.md) | [453](/filings/0000950170-25-105948.md) | [462](/filings/0001193125-25-272468.md) | [457](/filings/0001193125-26-340396.md) | [521](/filings/0001193125-26-215104.md) | [519](/filings/0001193125-26-340396.md) | | Long-term debt | $m | [156](/filings/0001628280-23-038372.md) | [157](/filings/0001628280-25-009207.md) | [157](/filings/0001628280-24-022356.md) | [157](/filings/0001628280-24-036484.md) | [158](/filings/0001628280-24-046662.md) | [369](/filings/0001193125-26-082535.md) | [367](/filings/0001628280-25-024788.md) | [338](/filings/0000950170-25-105948.md) | [339](/filings/0001193125-25-272468.md) | [340](/filings/0001193125-26-340396.md) | [403](/filings/0001193125-26-215104.md) | [404](/filings/0001193125-26-340396.md) | | Current portion of debt | $m | [4.9](/filings/0001628280-23-038372.md) | [4.1](/filings/0001628280-25-009207.md) | [13.2](/filings/0001628280-24-022356.md) | [12.6](/filings/0001628280-24-036484.md) | [19.1](/filings/0001628280-24-046662.md) | [12.2](/filings/0001193125-26-082535.md) | [12.0](/filings/0001628280-25-024788.md) | [14.2](/filings/0000950170-25-105948.md) | [14.4](/filings/0001193125-25-272468.md) | [13.6](/filings/0001193125-26-340396.md) | [12.3](/filings/0001193125-26-215104.md) | [12.3](/filings/0001193125-26-340396.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [414](/filings/0001628280-23-038372.md) | [446](/filings/0001628280-25-009207.md) | [433](/filings/0001628280-24-022356.md) | [471](/filings/0001628280-24-036484.md) | [459](/filings/0001628280-24-046662.md) | [418](/filings/0001193125-26-082535.md) | [406](/filings/0001628280-25-024788.md) | [390](/filings/0000950170-25-105948.md) | [369](/filings/0001193125-25-272468.md) | [358](/filings/0001193125-26-340396.md) | [325](/filings/0001193125-26-215104.md) | [295](/filings/0001193125-26-340396.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(14.8) d](/filings/0001628280-24-046662.md) | [(16.4) d](/filings/0001193125-26-082535.md) | [(9.3)](/filings/0001628280-25-024788.md) | [(19.7) d](/filings/0000950170-25-105948.md) | [(22.8) d](/filings/0001193125-25-272468.md) | [(6.7) d](/filings/0001193125-26-082535.md) | [(29.0)](/filings/0001193125-26-215104.md) | [(7.6) d](/filings/0001193125-26-340396.md) | [(6.2) d](/filings/0001193125-25-272468.md) | [(14.4) d](/filings/0001193125-26-082535.md) | [(22.1)](/filings/0001193125-26-215104.md) | [(28.9) d](/filings/0001193125-26-340396.md) | | Capital expenditure | $m | [2.0 d](/filings/0001628280-24-046662.md) | [4.2 d](/filings/0001193125-26-082535.md) | [2.3](/filings/0001628280-25-024788.md) | [3.7 d](/filings/0000950170-25-105948.md) | [6.5 d](/filings/0001193125-25-272468.md) | [1.8 d](/filings/0001193125-26-082535.md) | [2.4](/filings/0001193125-26-215104.md) | [6.0 d](/filings/0001193125-26-340396.md) | [4.2 d](/filings/0001193125-25-272468.md) | [1.7 d](/filings/0001193125-26-082535.md) | [3.2](/filings/0001193125-26-215104.md) | [3.1 d](/filings/0001193125-26-340396.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [121](/filings/0001628280-23-038372.md) | [131](/filings/0001628280-24-022356.md) | [142](/filings/0001628280-24-036484.md) | [147](/filings/0001628280-24-046662.md) | [165](/filings/0001628280-25-024788.md) | [170](/filings/0000950170-25-105948.md) | [179](/filings/0001193125-25-272468.md) | [191](/filings/0001193125-26-215104.md) | [195](/filings/0001193125-26-340396.md) | [199](/filings/0001193125-25-272468.md) | [207](/filings/0001193125-26-215104.md) | [212](/filings/0001193125-26-340396.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.